Ameliorating effects and mechanisms of transcutaneous auricular vagal nerve stimulation on abdominal pain and constipation

• Published in: JCI insight Vol. 6; no. 14
• Main Authors: Shi, Xiaodan, Hu, Yedong, Zhang, Bo, Li, Wenna, Chen, Jiande Dz, Liu, Fei
• Format: Journal Article
• Language: English
• Published: United States American Society for Clinical Investigation 22.07.2021; American Society for Clinical investigation
• Subjects: Abdominal Pain - diagnosis; Abdominal Pain - therapy; Adult; Aged; Clinical Medicine; Constipation - diagnosis; Constipation - therapy; Ear Auricle - innervation; Female; Gastroenterology; Humans; Irritable Bowel Syndrome - complications; Irritable Bowel Syndrome - diagnosis; Irritable Bowel Syndrome - therapy; Male; Middle Aged; Pain Measurement; Quality of Life; Transcutaneous Electric Nerve Stimulation - methods; Treatment Outcome; Vagus Nerve; Vagus Nerve Stimulation - methods; Pain; Gastroenterology
• ISSN: 2379-3708; 2379-3708
• DOI: 10.1172/jci.insight.150052

BackgroundAbdominal pain and constipation are 2 main symptoms in patients with constipation-predominant irritable bowel syndrome (IBS-C). This study aimed to investigate the effects and possible mechanisms of transcutaneous auricular vagal nerve stimulation (taVNS) in patients with IBS-C.MethodsForty-two patients with IBS-C were randomized into a 4-week sham-taVNS or taVNS treatment. The primary outcomes were complete spontaneous bowel movements per week (CSBMs/week) and visual analog scale (VAS) for abdominal pain. High-resolution anorectal manometry (HRAM) was performed to evaluate anorectal motor and sensory function. Cytokines and brain gut peptides were analyzed in blood samples. ECG was recorded for the assessment of autonomic function.ResultsCompared with sham-taVNS, (a) taVNS increased CSBMs/week (P = 0.001) and decreased VAS pain score (P = 0.001); (b) improved quality of life (P = 0.020) and decreased IBS symptom score (P = 0.001); (c) improved rectoanal inhibitory reflex (P = 0.014) and improved rectal sensation (P < 0.04); (d) decreased a number of proinflammatory cytokines and serotonin in circulation; and (e) enhanced vagal activity (P = 0.040). The vagal activity was weakly correlated with the CSBMs/week (r = 0.391; P = 0.010) and the VAS pain score (r = -0.347; P = 0.025).ConclusionsNoninvasive taVNS improves both constipation and abdominal pain in patients with IBS-C. The improvement in IBS-C symptoms might be attributed to the integrative effects of taVNS on intestinal functions mediated via the autoimmune mechanisms.Trial registrationwww.chictr.org.cn, no. ChiCTR2000029644.FundingNational Natural Science Foundation of China (grant no. 81970538 for FL).